MX348184B - Métodos y composiciones para tratar diarrea asociada con vih. - Google Patents

Métodos y composiciones para tratar diarrea asociada con vih.

Info

Publication number
MX348184B
MX348184B MX2013004873A MX2013004873A MX348184B MX 348184 B MX348184 B MX 348184B MX 2013004873 A MX2013004873 A MX 2013004873A MX 2013004873 A MX2013004873 A MX 2013004873A MX 348184 B MX348184 B MX 348184B
Authority
MX
Mexico
Prior art keywords
diarrhea
methods
compositions
treating hiv
associated diarrhea
Prior art date
Application number
MX2013004873A
Other languages
English (en)
Other versions
MX2013004873A (es
Inventor
Forbes William
Bortey Enoch
King Steven
Chaturvedi Pravin
Original Assignee
Napo Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45994461&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX348184(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Napo Pharmaceuticals Inc filed Critical Napo Pharmaceuticals Inc
Publication of MX2013004873A publication Critical patent/MX2013004873A/es
Publication of MX348184B publication Critical patent/MX348184B/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Se plantean en la presente métodos para tratar diarrea al administrar a un paciente en necesidad del mismo, un inhibidor de transporte de iones de cloruro en una cantidad suficiente para tratar diarrea. El tratamiento de diarrea incluye el tratamiento de diarrea así como el dolor, molestia abdominal y otros síntomas asociados con diarrea. En una modalidad, el inhibidor de transporte de iones de cloruro es crofelemer.
MX2013004873A 2010-10-31 2011-10-31 Métodos y composiciones para tratar diarrea asociada con vih. MX348184B (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US40862210P 2010-10-31 2010-10-31
US40933510P 2010-11-02 2010-11-02
US41624910P 2010-11-22 2010-11-22
US201161434379P 2011-01-19 2011-01-19
PCT/US2011/058549 WO2012058664A1 (en) 2010-10-31 2011-10-31 Methods and compositions for treating hiv-associated diarrhea

Publications (2)

Publication Number Publication Date
MX2013004873A MX2013004873A (es) 2013-08-21
MX348184B true MX348184B (es) 2017-06-02

Family

ID=45994461

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013004873A MX348184B (es) 2010-10-31 2011-10-31 Métodos y composiciones para tratar diarrea asociada con vih.

Country Status (19)

Country Link
US (4) US8962680B2 (es)
EP (1) EP2632550B1 (es)
JP (2) JP6063385B2 (es)
CN (2) CN107595836A (es)
AU (1) AU2011320155B2 (es)
BR (1) BR112013010774A2 (es)
CA (1) CA2816416C (es)
DK (1) DK2632550T3 (es)
EC (1) ECSP13012650A (es)
ES (1) ES2635435T3 (es)
HK (1) HK1249036A1 (es)
HU (1) HUE035393T2 (es)
MX (1) MX348184B (es)
PE (1) PE20140036A1 (es)
PL (1) PL2632550T3 (es)
PT (1) PT2632550T (es)
RU (1) RU2597746C2 (es)
WO (1) WO2012058664A1 (es)
ZA (1) ZA201303136B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2241318B1 (en) 2006-05-01 2012-12-19 Napo Pharmaceuticals, Inc. Method for treatment of constipation-predominant irritable bowel syndrome
US20070254050A1 (en) 2006-05-01 2007-11-01 Quart Barry D Method for treatment of diarrhea-predominant irritable bowel syndrome
ES2660551T3 (es) 2006-05-01 2018-03-22 Napo Pharmaceuticals, Inc. Composiciones y métodos para tratar o prevenir cáncer de colon
DK2632550T3 (en) 2010-10-31 2017-08-07 Napo Pharmaceuticals Inc METHODS AND COMPOSITIONS FOR TREATING HIV-ASSOCIATED DIARRIA
US20140163096A1 (en) * 2012-12-07 2014-06-12 Pam Golden Methods and compositions for treating hiv-associated diarrhea
US11389424B2 (en) 2017-03-09 2022-07-19 Napo Pharmaceuticals, Inc. Methods and compositions for treating chemotherapy-induced diarrhea
JOP20190275A1 (ar) 2017-05-31 2019-11-27 Napo Pharmaceuticals Inc طرق وتركيبات لعلاج اضطراب إسهال خِلقي
JOP20190276A1 (ar) 2017-05-31 2019-11-27 Napo Pharmaceuticals Inc طرق وتركيبات لعلاج إسهال الحمض الصفراوي، والإسهال المرتبط باستئصال الأمعاء الدقيقة أو إزالة المرارة، ومتلازمة الأمعاء القصيرة
EP3935581A4 (en) 2019-03-04 2022-11-30 Iocurrents, Inc. DATA COMPRESSION AND COMMUNICATION USING MACHINE LEARNING
BR112022025741A2 (pt) * 2020-06-19 2023-01-03 Napo Pharmaceuticals Inc Usos de composições compreendendo crofelemer para tratamento de diarreia induzida por quimioterapia (cid)
WO2022115481A1 (en) * 2020-11-24 2022-06-02 Napo Pharmaceuticals, Inc. Methods and compositions for treating post-acute infection gastrointestinal disorders

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5211944A (en) 1990-10-12 1993-05-18 Shaman Pharmaceuticals, Inc. Proanthocyanidin polymers having antiviral activity and methods of obtaining same
CA2269078C (en) * 1996-10-16 2012-01-24 Shaman Pharmaceuticals, Inc. Enteric formulations of proanthocyanidin polymer antidiarrheal compositions
WO2000047062A2 (en) 1999-02-01 2000-08-17 Shaman Pharmaceuticals, Inc. Enteric formulations of proanthocyanidin polymer dietary supplements and methods for preparing same
US20040071793A1 (en) 2002-10-05 2004-04-15 Bobrowski Paul J. Oral rehydration methods and compositions
US20080025966A1 (en) * 2004-01-30 2008-01-31 Currie Mark G Methods And Compositions For The Treatment Of Gastrointestinal disorders
AU2006262275A1 (en) * 2005-06-22 2007-01-04 The Massachusetts Institute Of Technology HIV-1 protease inhibitors, and methods of making and using them
CA2633417A1 (en) 2005-12-15 2007-06-21 Bayer Healthcare Ag Diaryl ureas for treating virus infections
US20070254050A1 (en) * 2006-05-01 2007-11-01 Quart Barry D Method for treatment of diarrhea-predominant irritable bowel syndrome
EP2241318B1 (en) * 2006-05-01 2012-12-19 Napo Pharmaceuticals, Inc. Method for treatment of constipation-predominant irritable bowel syndrome
ES2660551T3 (es) 2006-05-01 2018-03-22 Napo Pharmaceuticals, Inc. Composiciones y métodos para tratar o prevenir cáncer de colon
WO2010021681A2 (en) 2008-08-18 2010-02-25 Combinatorx (Singapore) Pte. Ltd. Compositions and methods for treatment of viral diseases
US7928115B2 (en) 2008-10-02 2011-04-19 Salix Pharmaceuticals, Ltd. Methods of treating travelers diarrhea and hepatic encephalopathy
WO2011024049A2 (en) 2009-08-26 2011-03-03 Glenmark Pharmaceuticals Ltd Method for producing proanthocyanidin polymer compositions for pharmaceutical formulations
US20120202876A1 (en) 2009-10-06 2012-08-09 Napo Pharmaceuticals, Inc. Methods of treating diseases with proanthocyanidin oligomers such as crofelemer
US20110087530A1 (en) 2009-10-09 2011-04-14 Visa U.S.A. Inc. Systems and Methods to Provide Loyalty Programs
DK2632550T3 (en) 2010-10-31 2017-08-07 Napo Pharmaceuticals Inc METHODS AND COMPOSITIONS FOR TREATING HIV-ASSOCIATED DIARRIA
WO2012101008A1 (en) 2011-01-27 2012-08-02 Glenmark Pharmaceuticals Limited Process for the production of proanthocyanidin polymeric composition
WO2013093655A1 (en) 2011-12-22 2013-06-27 Glenmark Pharmaceuticals Limited Non-enteric pharmaceutical composition comprising crofelemer
US20140163096A1 (en) 2012-12-07 2014-06-12 Pam Golden Methods and compositions for treating hiv-associated diarrhea

Also Published As

Publication number Publication date
PT2632550T (pt) 2017-08-02
ES2635435T3 (es) 2017-10-03
JP6310971B2 (ja) 2018-04-11
US9585868B2 (en) 2017-03-07
ECSP13012650A (es) 2013-10-31
JP6063385B2 (ja) 2017-01-18
DK2632550T3 (en) 2017-08-07
EP2632550A1 (en) 2013-09-04
HK1249036A1 (zh) 2018-10-26
PE20140036A1 (es) 2014-01-31
US8962680B2 (en) 2015-02-24
HUE035393T2 (en) 2018-05-02
MX2013004873A (es) 2013-08-21
CN107595836A (zh) 2018-01-19
AU2011320155B2 (en) 2016-02-25
PL2632550T3 (pl) 2017-10-31
JP2017019806A (ja) 2017-01-26
CN103370101A (zh) 2013-10-23
CA2816416A1 (en) 2012-05-03
US20120184605A1 (en) 2012-07-19
ZA201303136B (en) 2016-01-27
EP2632550A4 (en) 2014-04-23
RU2013123794A (ru) 2014-12-10
US20150190367A1 (en) 2015-07-09
CA2816416C (en) 2020-02-11
EP2632550B1 (en) 2017-05-03
BR112013010774A2 (pt) 2017-03-21
US20140294903A1 (en) 2014-10-02
WO2012058664A1 (en) 2012-05-03
AU2011320155A1 (en) 2013-05-09
JP2013540826A (ja) 2013-11-07
RU2597746C2 (ru) 2016-09-20
US20120107370A1 (en) 2012-05-03

Similar Documents

Publication Publication Date Title
MX348184B (es) Métodos y composiciones para tratar diarrea asociada con vih.
MX344238B (es) Compuestos de tetrazol y métodos para preparar y usar los mismos.
GB201318761D0 (en) Compounds for the treatment of neuropsychiatric disorders
GB201111485D0 (en) Drug composition and its use in therapy
AU2010300611A8 (en) Hematopoietic stem cells for use in the treatment of a kidney injury
MX2013006319A (es) Composiciones y metodos para tratar el cancer usando un inhibidor de pi3k y un inhibidor de mek.
MY175764A (en) Extended-release formulation for reducing the frequency of urination and method of use thereof
MX2014000066A (es) Formulaciones mucoadhesivas en gel de alta dosificación de metronidazol de base acuosa y su uso para tratar la vaginosis bacteriana.
EA201200428A1 (ru) Композиция и способ для лечения ожирения
WO2014071168A3 (en) Administering inhibitors of tgfbeta signaling to improve muscle function in cancer patients
MX2012013374A (es) Tratamiento de infecciones de clostridium difficile en pacientes bajo terapia con antibioticos.
JOP20190276A1 (ar) طرق وتركيبات لعلاج إسهال الحمض الصفراوي، والإسهال المرتبط باستئصال الأمعاء الدقيقة أو إزالة المرارة، ومتلازمة الأمعاء القصيرة
MY180772A (en) Novel therapeutic mirtazapine combinations for use in pain disorders
MX2014003873A (es) Metodo para tratar el carcinoma mucoepidermoide.
EA201071350A1 (ru) Композиции и способы для лечения воспаления роговицы
MX2022016367A (es) Metodos y composiciones para el tratamiento de la diarrea inducida por quimioterapia.
MY174065A (en) Methods and compositions for treating hiv-associated diarrhea
WO2012044963A3 (en) Perfluorocarbons for use in treating pruritus
EA201491836A1 (ru) Способы лечения рака с использованием ингибитора pi3k и ингибитора mek
UA60230U (ru) Способ лечения необратимых форм пульпитов
TN2013000247A1 (en) Compositions comprising a pi3k inhibitor and a mek inhibitor and their use for treating cancer
UA45538U (ru) Способ лечения астенического синдрома у пациентов урологического профиля
UA64165U (ru) Способ лечения пациентов с травмами мягких тканей конечностей
UA93416C2 (ru) Способ оценки симптомов преждевременной эякуляции
RU2012158011A (ru) Метод и композиция для лечения рака

Legal Events

Date Code Title Description
GB Transfer or rights

Owner name: NAPO PHARMACEUTICALS, INC.

FG Grant or registration